<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1813">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04689490</url>
  </required_header>
  <id_info>
    <org_study_id>CASVE PI-20-1894</org_study_id>
    <nct_id>NCT04689490</nct_id>
  </id_info>
  <brief_title>Prospective Study of Persistent Dyspnea in Recovered COVID-19 Patients</brief_title>
  <acronym>DISCOVID19</acronym>
  <official_title>Prospective Study of Persistent Dyspnea in Recovered COVID-19 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clínico Universitario de Valladolid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Clínico Universitario de Valladolid</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We conducted a national, single center (Hospital Clínico Universitario de Valladolid, Spain,&#xD;
      Valladolid), prospective study of patients with prior hospitalization because of COVID-19 who&#xD;
      were admitted between March 1st, 2020, and May 15th, 2020. All eligible patients underwent at&#xD;
      least at first-time follow-up from the index event. Exclusion criteria were age &lt; 18 years&#xD;
      old, pregnant women, terminally ill patients, active SARS-CoV-2 infections, inability to&#xD;
      exercise and previous known severe pulmonary or heart disease. Patients underwent a clinical&#xD;
      assessment for symptom burden, questionnaire for quality of life (Kansas City Cardiomyopathy&#xD;
      Questionnaire and SF-36), venous blood sampling, 6-minute walking test (6-MWT), tests of lung&#xD;
      function (spirometry and diffusing capacity of the lungs for carbon monoxide) and treadmill&#xD;
      cardio-pulmonary exercise testing (CPET). 48-hours before the test of lung function and the&#xD;
      CPET, all patients yielded a negative result in the reverse transcription-polymerase chain&#xD;
      reaction (RT-PCR) for SARS-CoV-2. For definitive analysis patients were assigned to the&#xD;
      control group if they did not refer dyspnea at the time of the follow-up, a small&#xD;
      asymptomatic out-patient control group without prior hospitalization was also included.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Aerobic capacity</measure>
    <time_frame>6 months</time_frame>
    <description>Measured as peak oxygen uptake</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Lung Capacity (TLC)</measure>
    <time_frame>6 months</time_frame>
    <description>Pulmonary function test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Force Expiratory Volume in 1 second (FEV1)</measure>
    <time_frame>6 months</time_frame>
    <description>Pulmonary function test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Difussing Lung Capacity of CO (DLCO)</measure>
    <time_frame>6 months</time_frame>
    <description>Pulmonary function test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forced Vital Capacity (FVC)</measure>
    <time_frame>6 months</time_frame>
    <description>Pulmonary function test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Left Ventricular (LV) Function</measure>
    <time_frame>6 months</time_frame>
    <description>Left Ventricular (LV) Function (Ecocardiagraphy-measured Cardiac Function)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Right Ventricular (RV) Function</measure>
    <time_frame>6 months</time_frame>
    <description>Right Ventricular (RV) Function (Ecocardiagraphy-measured Cardiac Function)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Short Form 36 Health Survey (SF-36)</measure>
    <time_frame>6 months</time_frame>
    <description>Quality of Life test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kansas City Cardiomyopathy Questionnaire (KCCQ)</measure>
    <time_frame>6 Months</time_frame>
    <description>Quality of Life test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 Minute Walk Test</measure>
    <time_frame>6 months</time_frame>
    <description>Walking capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>N-terminal pro hormone B-type natriuretic peptide (NT-proBNP)</measure>
    <time_frame>6 months</time_frame>
    <description>Inflammatory and Cardiac Marker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Troponin-T</measure>
    <time_frame>6 months</time_frame>
    <description>Inflammatory and Cardiac Marker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ferritin</measure>
    <time_frame>6 months</time_frame>
    <description>Inflammatory and Cardiac Marker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>D-Dimer</measure>
    <time_frame>6 months</time_frame>
    <description>Inflammatory and Cardiac Marker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>interleukine-6</measure>
    <time_frame>6 months</time_frame>
    <description>Inflammatory and Cardiac Marker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C reactive protein (CRP)</measure>
    <time_frame>6 months</time_frame>
    <description>Inflammatory and Cardiac Marker</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Covid19</condition>
  <condition>Dyspnea</condition>
  <arm_group>
    <arm_group_label>Dyspnea</arm_group_label>
    <description>Patients with prior hospitalization because of COVID-19, with succesful hospital discharge, who underwent at least a first-time follow-up from the index event, and present persistent dyspnea.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Patients with prior hospitalization because of COVID-19, with succesful hospital discharge, who underwent at least a first-time follow-up from the index event, fully recovered, without persistent dyspnea.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cardiopulmonary exercise test</intervention_name>
    <description>Only diagnostic tests</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Dyspnea</arm_group_label>
    <other_name>walking test</other_name>
    <other_name>pulmonary lung test</other_name>
    <other_name>echocardiography</other_name>
    <other_name>blood sampling</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with prior hospitalization because of COVID-19 who were admitted between March and&#xD;
        May. All eligible patient underwent at least at first-time follow-up from the index event.&#xD;
        Exclusion criteria were age &lt; 18 years old, pregnant women, terminally ill patients, active&#xD;
        SARS-CoV-2 infections, inability to exercise and previous known severe pulmonary or heart&#xD;
        disease.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Signed Informed Consent&#xD;
&#xD;
          -  Previous COVID-19 hospitalization with successful discharged&#xD;
&#xD;
          -  Availability of at least one follow up per clinical protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnant women&#xD;
&#xD;
          -  terminally ill patients&#xD;
&#xD;
          -  active SARS-CoV-2 infections&#xD;
&#xD;
          -  inability to exercise&#xD;
&#xD;
          -  previous known severe pulmonary or heart disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Álvaro Aparisi, MD</last_name>
    <phone>+34 983 420000</phone>
    <phone_ext>86571</phone_ext>
    <email>alvaro_aparisi@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <zip>47003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Álvaro Aparisi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Álvaro Aparisi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ignacio J Amat-Santos, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina Ybarra-Falcón, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Javier Tobar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carolina Iglesias-Echeverria, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mario García-Gómez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alberto San Román, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Pinney SP, Giustino G, Halperin JL, Mechanick JI, Neibart E, Olin JW, Rosenson RS, Fuster V. Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes: JACC Focus Seminar. J Am Coll Cardiol. 2020 Oct 27;76(17):1999-2010. doi: 10.1016/j.jacc.2020.08.058. Review.</citation>
    <PMID>33092736</PMID>
  </reference>
  <reference>
    <citation>Ahmed H, Patel K, Greenwood DC, Halpin S, Lewthwaite P, Salawu A, Eyre L, Breen A, O'Connor R, Jones A, Sivan M. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med. 2020 May 31;52(5):jrm00063. doi: 10.2340/16501977-2694.</citation>
    <PMID>32449782</PMID>
  </reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 17, 2020</study_first_submitted>
  <study_first_submitted_qc>December 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 30, 2020</study_first_posted>
  <last_update_submitted>December 29, 2020</last_update_submitted>
  <last_update_submitted_qc>December 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clínico Universitario de Valladolid</investigator_affiliation>
    <investigator_full_name>Ignacio J. Amat Santos</investigator_full_name>
    <investigator_title>Coordinator of Interventional Cardiology Unit</investigator_title>
  </responsible_party>
  <keyword>Dyspnea</keyword>
  <keyword>Covid19</keyword>
  <keyword>Cardiopulmonary exercise test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspnea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

